Hungary vs Turkey: Cause of death, by non-communicable diseases, ages 5-14, male
Hungary
53.0%
in 2021
Turkey
52.5%
in 2021
Hungary rank
44th
Turkey rank
45th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Hungary
- Turkey
How they compare
Hungary currently reports 53.0% against 52.5% in Turkey, a difference of 0.5%.
Across all 6 years both countries report, Hungary has been ahead every year.
Hungary ranks 44th and Turkey ranks 45th of 185 countries.
Hungary has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.7% | 44.9% | 5.8% | Hungary |
| 2010s | 64.2% | 53.3% | 10.9% | Hungary |
| 2020s | 61.2% | 53.1% | 8.2% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Hungary or Turkey?
- Hungary, at 53.0% against 52.5% in Turkey as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Hungary and Turkey?
- 0.5%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Turkey?
- 6 years are reported by both, from 2000 to 2021.
- How do Hungary and Turkey rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Hungary ranks 44th and Turkey ranks 45th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.